ClinicalTrials.gg
CompletedNCT02944877Updated Oct 29, 2024Results posted

HOPE Social Media Intervention for HIV Testing and Studying Social Networks

An interventional study of social media intervention in HIV, sponsored by University of California, Irvine. Completed at 1 site in United States. Open to male participants aged 18 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-29.

Sponsored by University of California, Irvine · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
900
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
Male
01

Study summary

This study [HOPE: Harnessing Online Peer Education] seeks to determine the efficacy of using online social networks to scale peer community leader models to increase HIV prevention within African-American and Latino men who have sex with men. The peer community leader model, which teaches community popular opinion leaders about how to disseminate behavior changes messages throughout the community, has been proven to increase HIV prevention behaviors. Social media and online communities, such as Facebook, may be a cost-effective platform for scaling these models. Primarily upper middle-class White populations used the Internet in its early years, however, Internet use within African-American and Latino households has recently increased dramatically, especially on social media. People using the Internet may be at the highest risk for contracting HIV and are using novel Internet approaches to find sex partners, such as through social media. This is the first study to examine the effectiveness of the HOPE social media intervention to increase HIV testing among at-risk groups in the United States.

02

Conditions studied

  • HIV
03

In context

Lead sponsor

University of California, Irvine is the lead sponsor of 474 studies on the registry; 96 are open to participants now.

Of its 41 completed or terminated interventional studies of FDA-regulated products, 30 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older
  • Male
  • Sexually active with another man in the last 12 months
  • Willing and capable of understanding and assenting to an online informed consent form
  • Has (or willing to create) a social media page.

Exclusion criteria

Exclusion Criteria:

  • Does not satisfy inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
900 participants (actual)

Study arms

  • Experimental
    intervention

    experimental

    Behavioral: social media intervention

  • Other
    control

    Other

    Behavioral: social media intervention

Interventions

  • Behavioralsocial media intervention

    social media intervention

06

What researchers measure

Primary outcomes

  1. Number of Participants Requesting HIV Self-Testing

    At home/self HIV testing kits can be requested to be ordered and will be provided to all participants who request it.

    Time frame: 5 years

07

Results

Posted Oct 29, 2024

Participant flow

Participant flow — Overall Study
MilestoneInterventionControl
Started450450
Completed421418
Not completed2932

Outcome measures

PrimaryNumber of Participants Requesting HIV Self-Testing

At home/self HIV testing kits can be requested to be ordered and will be provided to all participants who request it.

Time frame:
5 years
Reported as:
Count of participants · Participants
Number of Participants Requesting HIV Self-Testing
ParticipantsInterventionControl
Number of Participants Requesting HIV Self-Testing130102

Adverse events

Collected over 12 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/450 (0%)0/450 (0%)0/450 (0%)
Control0/450 (0%)0/450 (0%)0/450 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)InterventionControlTotal
Mean32 ± 9.831 ± 8.832 ± 8.8
Sex: Female, Male
Sex: Female, Male(Participants)InterventionControlTotal
Female000
Male450450900
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)InterventionControlTotal
Race/Ethnicity — White/European Descent392867
Race/Ethnicity — Latino/Caribbean301319620
Race/Ethnicity — Black/African American7273145
Race/Ethnicity — American Indian or Alaska Native8715
Race/Ethnicity — Asian or Pacific Islander181634
Race/Ethnicity — Other12719
Region of Enrollment
Region of Enrollment(participants)InterventionControlTotal
United States450450900
08

Study locations

1 site
  • University of California Irvine
    Irvine, California 92697, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 1, 2014

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02944877
Responsible party
Sean D Young (Associate Professor of Emergency Medicine and Informatics, University of California, Irvine) — Principal investigator
First posted
Oct 26, 2016
Start date
Dec 2016
Primary completion
Jan 31, 2021
Completion
Jan 31, 2023
Results posted
Oct 29, 2024
Last update
Oct 29, 2024

Study contacts

Sean Young
principal investigator · University of California, Irvine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion